广东丹霞生物制药

Guangdong Danxia Biological Pharmaceutical is a Chinese biopharmaceutical company specializing in the research, development, and production of plasma-derived medicinal products (PDMPs). The company operates a large-scale manufacturing facility in Shaoguan, Guangdong, and manages multiple plasma collection centers across China to ensure a stable supply chain. Its product portfolio includes human albumin, intravenous immunoglobulin (IVIG), and various specific immunoglobulins and coagulation factors. As a subsidiary of Luye Life Sciences Group, Danxia Bio is a key player in the Chinese blood products market, focusing on addressing critical needs in immunology, emergency medicine, and hematology.